Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2019;16:535–48. https://doi.org/10.1038/s41571-019-0194-4.

CAS  Article  PubMed  Google Scholar 

Chan AM, Baehring JM. Paraneoplastic neurological syndromes: a single institution 10-year case series. J Neurooncol. 2019;141:431–9. https://doi.org/10.1007/s11060-018-03053-3.

Article  PubMed  Google Scholar 

Lorusso L, Precone V, Hart IK, Giometto B, Pezzani R, Ngonga GK, et al. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study. J Biosci. 2021;46:13. https://doi.org/10.1007/s12038-020-00128-0.

CAS  Article  PubMed  Google Scholar 

Hébert J, Riche B, Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, et al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol neuroinflammation. 2020;7: e883. https://doi.org/10.1212/NXI.0000000000000883.

Article  Google Scholar 

Lorusso L, Precone V, Ferrari D, Ngonga GK, Russo AG, Paolacci S, et al. Paraneoplastic neurological syndromes: study of prevalence in a province of the Lombardy region Italy. J Clin Med. 2020;9:1–8. https://doi.org/10.3390/jcm9103105.

Article  Google Scholar 

Corsellis JAN, Goldberg GJ, Norton AR. ‘Limbic encephalitis’ and its association with carcinoma. Brain. 1968;91:481–96. https://doi.org/10.1093/brain/91.3.481.

CAS  Article  PubMed  Google Scholar 

Graus F, Cordon-Cardo C, Posner JB, F G, C C-C, and JB P. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985; 35: 538–43. https://doi.org/10.1212/wnl.35.4.538.

Graus F, Vogrig A, Muñiz-Castrillo S, Antoine J-CGCG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 2021; 8: e1014. https://doi.org/10.1212/NXI.0000000000001014. Important paper revising the old criteria for paraneoplastic neurologic syndromes.

Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36. https://doi.org/10.1002/ana.21050.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev. 2017;97:839–87. https://doi.org/10.1152/PHYSREV.00010.2016.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, et al. Advances in cancer immunotherapy 2019 - Latest trends. J Exp Clin Cancer Res. 2019; 38.https://doi.org/10.1186/s13046-019-1266-0

Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto AL, et al. Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. Neurol Neuroimmunol NeuroInflammation. 2019;6: e604. https://doi.org/10.1212/NXI.0000000000000604. Relevant demonstration that immune checkpoint inhibitors are actually able to increase the frequency of paraneoplastic syndromes.

Article  Google Scholar 

Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40. https://doi.org/10.1136/jnnp.2003.034447.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Devine MF, Kothapalli N, Elkhooly M, and Dubey D. Paraneoplastic neurological syndromes: clinical presentations and management. Ther. Adv. Neurol. Disord. 2021; 14. https://doi.org/10.1177/1756286420985323. Excellent review on paraneoplastic neurological syndromes.

Sechi E, Flanagan EP. Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front Neurol. 2021;12: 673339. https://doi.org/10.3389/fneur.2021.673339.

Article  PubMed  PubMed Central  Google Scholar 

Sabater L, Höftberger R, Boronat A, Saiz A, Dalmau J, Graus F. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS ONE. 2013;8: e60438. https://doi.org/10.1371/journal.pone.0060438.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hardy-Werbin M, Arpí O, Taus A, Rocha P, Joseph-Pietras D, Nolan L, et al. Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab. Oncoimmunology 2018; 7. https://doi.org/10.1080/2162402X.2017.1395125.

Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol. 2009;27:4260–7. https://doi.org/10.1200/JCO.2008.20.6169.

CAS  Article  PubMed  Google Scholar 

Graus F, Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2012;25:795–801. https://doi.org/10.1097/WCO.0b013e328359da15.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zoccarato M, Gastaldi M, Zuliani L, Biagioli T, Brogi M, Bernardi G, et al. Diagnostics of paraneoplastic neurological syndromes. Neurol Sci. 2017;38:237–42. https://doi.org/10.1007/s10072-017-3031-5.

Article  PubMed  Google Scholar 

Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77. https://doi.org/10.1016/s1474-4422(13)70282-5.

CAS  Article  PubMed  Google Scholar 

Lancaster E, Lai M, Peng X, Hughes EG, Constantinescu R, Raizer J, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–9.

CAS  Article  Google Scholar 

Gastaldi M, Mariotto S, Giannoccaro MP, Iorio R, Zoccarato M, Nosadini M, et al. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study. Eur J Neurol. 2020;27:633–43. https://doi.org/10.1111/ene.14139.

CAS  Article  PubMed  Google Scholar 

McCracken L, Zhang J, Greene M, Crivaro A, Gonzalez J, Kamoun M, et al. Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol neuroinflammation. 2017;4: e404. https://doi.org/10.1212/nxi.0000000000000404.

Article  Google Scholar 

Moll JWB, Vecht CJ, Henzen-Logmans SC, Van Der Burg MEL, Splinter TAW. Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system. J Neurol Neurosurg Psychiatry. 1990;53:940–3. https://doi.org/10.1136/jnnp.53.11.940.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Gastaldi M, Zardini E, Scaranzin S, Uccelli A, Andreetta F, Baggi F, et al. Autoantibody diagnostics in neuroimmunology: experience from the 2018 Italian Neuroimmunology Association External Quality Assessment Program. Front Neurol. 2019;10:1385. https://doi.org/10.3389/fneur.2019.01385.

Article  PubMed  Google Scholar 

Gorr T, Vogel J. Western blotting revisited: critical perusal of underappreciated technical issues. Proteomics - Clin Appl. 2015;9:396–405. https://doi.org/10.1002/prca.201400118.

CAS  Article  PubMed  Google Scholar 

Sabater L, Saiz A, Dalmau J, Graus F. Pitfalls in the detection of CV2 (CRMP5) antibodies. J Neuroimmunol. 2016;290:80–3. https://doi.org/10.1016/j.jneuroim.2015.11.009.

CAS  Article  PubMed  Google Scholar 

Budhram A, Nicolle MW, Yang L. The positive predictive value of onconeural antibody testing: a retrospective review. Can J Neurol Sci. 2018;45:577–9. https://doi.org/10.1017/cjn.2018.74.

Article  PubMed  Google Scholar 

Franciotta D, Gastaldi M, Biagioli T, Benedetti L, Giannotta C, Bedin R, et al. Anti-ganglioside antibodies: experience from the Italian Association of Neuroimmunology external quality assessment scheme. Clin Chem Lab Med. 2018;56:1921–5. https://doi.org/10.1515/cclm-2018-0234.

CAS  Article  PubMed  Google Scholar 

Déchelotte B, Muñiz-Castrillo S, Joubert B, Vogrig A, Picard G, Rogemond V, et al. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 2020; 7. https://doi.org/10.1212/NXI.0000000000000701.

Sabater L, Titulaer M, Saiz A, Verschuuren J, Güre AO, Graus F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology. 2008;70:924–8. https://doi.org/10.1212/01.wnl.0000281663.81079.24.

CAS  Article  PubMed  Google Scholar 

Carvajal-Gonzalez A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain. 2014;137:2178–92. https://doi.org/10.1093/brain/awu142.

Article  PubMed  PubMed Central  Google Scholar 

Titulaer MJ, Lang B, Verschuuren JJGM. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10:1098–107. https://doi.org/10.1016/S1474-4422(11)70245-9.

Article  PubMed  Google Scholar 

Ruiz-García R, Muñoz-Sánchez G, Naranjo L, Guasp M, Sabater L, Saiz A, et al. Limitations of a commercial assay as diagnostic test of autoimmune encephalitis. Front Immunol 2021; 12. https://doi.org/10.3389/fimmu.2021.691536.

Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123:1481–94. https://doi.org/10.1093/brain/123.7.1481.

Article  PubMed  Google Scholar 

Dreessen J, Jeanjean AP, and Sindic CJM. Paraneoplastic limbic encephalitis: diagnostic relevance of CSF analysis and total body PET scanning. Acta Neurol Belg 2004; 104: 57–63.https://pubmed.ncbi.nlm.nih.gov/15508268/ (accessed 6 Oct 2021).

Dadparvar S, Anderson GS, Bhargava P, Guan L, Reich P, Alavi A, et al. Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings. Clin Nucl Med. 2003;28:893–6. https://doi.org/10.1097/01.rlu.0000093284.54060.aa.

Article  PubMed  Google Scholar 

Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008;83:917–22. https://doi.org/10.4065/83.8.917.

Article  PubMed  Google Scholar 

Meglič B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185:135–8. https://doi.org/10.1016/S0022-510X(01)00467-1.

Article  PubMed  Google Scholar 

Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–48. https://doi.org/10.1093/brain/124.6.1138.

CAS  Article  PubMed  Google Scholar 

Bernal F, Shams’Ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 2003; 60: 230–4. https://doi.org/10.1212/01.WNL.0000041495.87539.98.

Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol. 2003;53:580–7. https://doi.org/10.1002/ana.10518.

CAS  Article  PubMed